Recce eyes US Defence grants with early data for R327 on burn wounds
Recce Pharma (ASX:RCE) has notched modest gains in the Tuesday arvo session after reporting its R327 anti-infective gel...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
PAG | Ann: REMOVAL FROM OFFICIAL LIST - close of trade | 04/11/13 | 0 | 1.1K | |||
|
|||||||
PAG | Ann: Scheme of Arrangement Implemented | 04/11/13 | 0 | 1.6K | |||
|
|||||||
PAG | Ann: Record Date and Final Distribution | 28/10/13 | 0 | 818 | |||
|
|||||||
PAG | Ann: Change in substantial holding | 23/10/13 | 0 | 872 | |||
|
|||||||
PAG | Ann: SUSPENSION FROM OFFICIAL QUOTATION-Close of | 21/10/13 | 0 | 787 | |||
|
|||||||
PAG | Ann: Court Order Lodgement | 21/10/13 | 0 | 616 | |||
|
|||||||
PAG | Ann: Court Approves Scheme | 18/10/13 | 0 | 701 | |||
|
|||||||
PAG | Ann: Trust Account Deed Poll | 17/10/13 | 0 | 717 | |||
|
See All Discussions